Predicting the Future: The Promise of New Tests for Prostate Cancer

Speaker: Dr. John Lewis
Original Date: Tuesday, July 22, 2014
 

Join Dr. John Lewis as he presents "Predicting the Future: The Promise of New Tests for Prostate Cancer."
 
Overview:
During this webinar, Dr. John Lewis will be discussing the use of biomarkers in prostate cancer diagnosis, including:

  • How biomarkers such as PSA are used today for prostate cancer management
  • How new biomarkers will allow patients and their physicians to make better treatment decisions

Speaker – Dr. John Lewis

Dr. John Lewis holds the Frank and Carla Sojonky Chair in Prostate Cancer Research at the University of Alberta. He is an Associate Professor in the Department of Oncology, a Fellow of the National Institute of Nanotechnology, and currently serves as the chair of the Alberta Prostate Cancer Research Initiative (APCaRI).  Dr. Lewis received his B.Sc. Honours in Genetics at University of Western Ontario in the Department of Genetics and a PhD in Biochemistry at the University of Victoria in 2003. He pursued post-doctoral training in Nanotechnology and Imaging at The Scripps Research Institute in La Jolla, CA. Dr. Lewis's research group utilizes real-time intravital imaging of cancer to learn about the critical steps of disease progression. They have developed several innovative nanoparticle platforms for the early detection of cancer, drug delivery, and the study of cancer invasion and metastasis. Dr. Lewis is actively involved in advocacy and public awareness programs for prostate cancer, and enjoys surfing, snowboarding and mountain biking in his spare time. 

About Expert Angle

Expert AngleExpert Angle is designed to expand our reach and address the many varied and complex questions that come with a prostate cancer diagnosis. These webinars will address topics important to men with prostate cancer along different points of the cancer care continuum and those within their circle of care as well as the general public and representatives from the clinical community.
 
The meetings are hosted using interactive on-line technology and feature leading experts in prostate cancer - making them accessible to anyone, regardless of their location, within Canada. The platform allows PCC to communicate directly with individuals in a variety of settings (i.e. in their homes, support group meetings, community centres) and geographic locations (i.e. urban, rural and remote locations) as well as measure engagement.   

View more Expert Angle webinars.

   

Plaid for Dad


Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Honouring dad this Father’s Day the Canadian way: In plaid

TORONTO, ON – (May 8, 2018) – Plaid replaces business-casual on Friday, June 15 as hundreds of thousands of Canadians don the iconic Canadian attire all to honour dad and end prostate cancer.
More

The Finger – A tried and true method to save lives

TORONTO, CANADA (May 8, 2018) – Every day, more and more methods to detect prostate cancer are being explored, but the tried and true methods of a digital rectal examination (DRE) – where a healthcare professional inserts a gloved finger into the rectum to check for abnormalities, paired with a blood test known as the prostate-specific antigen (PSA) test – which you can get through your family doctor, are still the long-standing proven ways to save a life.
More

Landmark study links tumour evolution to prostate cancer severity

Toronto (April 19, 2018) – Findings from Canadian Prostate Cancer Genome Network (CPC-GENE) researchers and their collaborators, published today in Cell, show that the aggressiveness of an individual prostate cancer can be accurately assessed by looking at how that tumour has evolved.
More


Click here for news archive